Cargando…

Complement Binding Anti-HLA Antibodies and the Survival of Kidney Transplantation

Background: Antibody-mediated rejection (AMR) is one of the most important challenges in the context of renal transplantation, because the binding of de novo donor-specific antibodies (dnDSA) to the kidney graft triggers the activation of the complement, which in turn leads to loss of transplant. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñoz-Herrera, Claudia M., Gutiérrez-Bautista, Juan Francisco, López-Nevot, Miguel Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057312/ https://www.ncbi.nlm.nih.gov/pubmed/36983335 http://dx.doi.org/10.3390/jcm12062335

Ejemplares similares

Clinical Case: Patient with Mixed Graft Rejection Four Days after Kidney Transplantation Developed Specific Antibodies against Donor Bw4 Specificities
por: Muñoz-Herrera, Claudia M., et al.
Publicado: (2021)

Complement-Binding Donor-Specific Anti-HLA Antibodies: Biomarker for Immunologic Risk Stratification in Pediatric Kidney Transplantation Recipients
por: Sigurjonsdottir, Vaka K., et al.
Publicado: (2022)

Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients
por: de Sousa, Marcos Vinicius, et al.
Publicado: (2018)

De Novo Complement-Binding Anti-HLA Antibodies in Heart Transplanted Patients Is Associated with Severe Cardiac Allograft Vasculopathy and Poor Long-Term Survival
por: Baudry, Guillaume, et al.
Publicado: (2022)

Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis
por: Bouquegneau, Antoine, et al.
Publicado: (2018)

Imlifidase for the treatment of anti‐HLA antibody‐mediated processes in kidney transplantation
por: Huang, Edmund, et al.
Publicado: (2021)

Correction: Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis
por: Bouquegneau, Antoine, et al.
Publicado: (2018)

Intra-operative kinetics of anti-HLA antibody in simultaneous liver-kidney transplantation
por: Kueht, M., et al.
Publicado: (2021)

Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2018)

HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine
por: Gutiérrez-Bautista, Juan Francisco, et al.
Publicado: (2022)

Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients
por: Gutiérrez-Bautista, Juan Francisco, et al.
Publicado: (2022)

Anti-HLA and Anti-MICA Antibodies in Liver Transplant Recipients: Effect on Long-Term Graft Survival
por: Ciszek, Michał, et al.
Publicado: (2013)

Bortezomib-Containing Multimodality Treatment for Antibody-Mediated Rejection with Anti-HLA and Anti-AT1R Antibodies after Kidney Transplantation
por: Iesari, Samuele, et al.
Publicado: (2017)

Complement-activating donor-specific anti-HLA antibodies in solid organ transplantation: systematic review, meta-analysis, and critical appraisal
por: Al-Awadhi, Solaf, et al.
Publicado: (2023)

Clinical Relevance of HLA Antibody Monitoring after Kidney Transplantation
por: Morath, Christian, et al.
Publicado: (2014)

Non-HLA Antibodies in Kidney Transplantation: Immunity and Genetic Insights
por: Sorohan, Bogdan Marian, et al.
Publicado: (2022)

Complement in Kidney Transplantation
por: Cernoch, Marek, et al.
Publicado: (2017)

HLA-DRB1∗16:01 and HLA-DQB1∗05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma
por: Wang, Xu, et al.
Publicado: (2021)

The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression
por: Habets, Thomas H. P. M., et al.
Publicado: (2018)

Misidentification of preformed anti-HLA-DP antibodies leads to antibody-mediated kidney transplant rejection: a case report
por: Thammanichanond, Duangtawan, et al.
Publicado: (2022)

Characteristics and Clinical Significance of De Novo Donor-Specific Anti-HLA Antibodies after Kidney Transplantation
por: Jung, Hee-Yeon, et al.
Publicado: (2018)

The Kinetics of Anti-HLA Antibodies in the First Year after Kidney Transplantation: In Whom and When Should They Be Monitored?
por: de Castro, Maria Cristina Ribeiro, et al.
Publicado: (2018)

Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets
por: Rijkers, Maaike, et al.
Publicado: (2019)

An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies
por: Prémaud, Aurélie, et al.
Publicado: (2017)

Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation
por: Morath, Christian, et al.
Publicado: (2020)

A closer look at rituximab induction on HLA antibody rebound following HLA incompatible kidney transplantation
por: Jackson, Annette M., et al.
Publicado: (2014)

Importance and What to Watch Out for De Novo Donor Specific Anti-HLA Antibodies after Kidney Transplantation
por: Yang, Chul Woo
Publicado: (2018)

Circulating Donor-Specific Anti-HLA Antibodies Associate With Immune Activation Independent of Kidney Transplant Histopathological Findings
por: Van Loon, Elisabet, et al.
Publicado: (2022)

Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients
por: Lee, Haeun, et al.
Publicado: (2023)

An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA
por: Thomas, K A, et al.
Publicado: (2015)

The Complement System in Kidney Transplantation
por: Santarsiero, Donata, et al.
Publicado: (2023)

Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
por: Park, Ji Eun, et al.
Publicado: (2018)

Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients
por: Park, Borae Geum, et al.
Publicado: (2019)

Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection
por: Crespo, Marta, et al.
Publicado: (2021)

The Pre-Transplant Non-HLA Antibody Burden Associates With the Development of Histology of Antibody-Mediated Rejection After Kidney Transplantation
por: Senev, Aleksandar, et al.
Publicado: (2022)

Living Donor Kidney Transplantation in Patients With Donor-Specific HLA Antibodies After Desensitization With Immunoadsorption
por: Kälble, Florian, et al.
Publicado: (2021)

Treatment of Anti-HLA Donor-Specific Antibodies Results in Increased Infectious Complications and Impairs Survival after Liver Transplantation
por: Ünlü, Sinem, et al.
Publicado: (2020)

Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies
por: Taylor, Craig J., et al.
Publicado: (2017)

Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
por: Morin-Zorman, Sarah, et al.
Publicado: (2016)

Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
por: Fichtner, Alexander, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vm761u4vr78a154sugdojfpr5g